21-Hydroxypregn-4-ene-3,20-dione(CAS: 64-85-7)

21-Hydroxypregn-4-ene-3,20-dione (CAS: 64-85-7) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the EU, and FDA and EPA guidelines in the USA. Specific safety data sheets (SDS) must be provided for handling and storage. Compliance with local and international regulations is essential to ensure safe and legal transport and usage.

Alternatives to 21-Hydroxypregn-4-ene-3,20-dione (CAS: 64-85-7) in synthesis include related steroids and analogs such as progesterone and its derivatives. Isomers and synthetic intermediates like 17α-hydroxy-17,20-dione can also serve as effective alternatives depending on the specific reaction conditions and desired product.

Market trends for 21-Hydroxypregn-4-ene-3,20-dione (CAS: 64-85-7) are influenced by increasing research in endocrine-disrupting chemicals and their role in health. There is a growing interest in its use as a research tool in endocrinology and pharmacology. Additionally, its potential applications in hormone replacement therapy and reproductive health are areas of active research, driving demand.

Waste containing 21-Hydroxypregn-4-ene-3,20-dione (CAS: 64-85-7) should be collected in appropriate containers and stored separately to prevent contamination. Proper disposal should follow local regulations, often requiring professional waste disposal services. Environmental protection measures include neutralization to reduce toxicity before disposal to ensure minimal impact on the environment.